Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Alterations in cerebrovascular regulation related to vascular oxidative stress have been implicated in the mechanisms of Alzheimer's disease (AD), but their role in the amyloid deposition and cognitive impairment associated with AD remains unclear. We used mice overexpressing the Swedish mutation of the amyloid precursor protein (Tg2576) as a model of AD to examine the role of reactive oxygen species produced by NADPH oxidase in the cerebrovascular alterations, amyloid deposition, and behavioral deficits observed in these mice. We found that 12- to 15-month-old Tg2576 mice lacking the catalytic subunit Nox2 of NADPH oxidase do not develop oxidative stress, cerebrovascular dysfunction, or behavioral deficits. These improvements occurred without reductions in brain amyloid-β peptide (Aβ) levels or amyloid plaques. The findings unveil a previously unrecognized role of Nox2-derived radicals in the behavioral deficits of Tg2576 mice and provide a link between the neurovascular dysfunction and cognitive decline associated with amyloid pathology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Experimental studies suggest that radicals produced by the enzyme nicotinamide adenine dinucleotide phosphate oxidase are responsible for the cerebrovascular alterations induced by VCI risk factors and Aβ.112,122–124”
From Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association (2011) · cites this paper as [124]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Converging evidence suggests that amyloid-β and tau-related pathology contribute to chronic hypoperfusion of white matter tissue (Iadecola et al., 1999; Park et al., 2008).”
From White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer’s disease (2018) · cites this paper as Park et al., 2008
Experimental — accuracy not yet measuredIn the citing paper
“The vascular alterations induced by Aβ are abrogated by overexpression of the ROS scavenging enzyme superoxide dismutase or deficiency of the NADPH oxidase subunit NOX2 (Iadecola et al., 1999; Park et al., 2005; 2008)”
From The Pathobiology of Vascular Dementia (2013) · cites this paper as Park et al., 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
Bedard, K., & Krause, K.-H. (2007) · Physiological Reviews · doi:10.1152/physrev.00044.2005 · Cited by 6,989 · cited 1×
“A major source of ROS in brain and blood vessels is the superoxide-producing enzyme NADPH oxidase (20).”
BackgroundSoluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744 · cited 4×
“The mechanisms by which A leads to cognitive impairment have not been completely elucidated, although recent evidence suggests that small aggregates of A may be key pathogenic factors by disrupting synaptic function and inducing neuronal death (2).”
BackgroundInfluentialCorrelative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210 · cited 3×
“We studied crosses between Tg2576 mice (22) and mice deficient in the Nox2 catalytic subunit of NADPH oxidase (24).”
BackgroundSelf-citationNeurovascular regulation in the normal brain and in Alzheimer's disease
Iadecola, C. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1387 · Cited by 2,213 · cited 3×
“The harmful cerebrovascular effects of A , in concert with epidemiological and pathological findings linking AD with cerebrovascular diseases (12–16), have suggested that A has deleterious actions both on neurons and cerebral blood vessels, which may act synergistically to induce brain dysfunction in AD (3, 17).”
BackgroundSelf-citationBrain Infarction and the Clinical Expression of Alzheimer Disease<subtitle>The Nun Study</subtitle>
Snowdon, D. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540340047031 · Cited by 1,590
Lim, G. P., Chu, T., Yang, F., Beech, W., Frautschy, S. A., & Cole, G. M. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-21-08370.2001 · Cited by 1,530 · cited 1×
“Conversely, the free radical scavenger curcumin reduced amyloid load in mice overexpressing APP (40, 44).”
BackgroundKawarabayashi, T., Younkin, L. H., Saido, T. C., Shoji, M., Ashe, K. H., & Younkin, S. G. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-02-00372.2001 · Cited by 1,053
Self-citationPollock, J. D., Williams, D. A., Gifford, M. A. C., Li, L. L., Du, X., Fisherman, J., Orkin, S. H., Doerschuk, C. M., & Dinauer, M. C. (1995) · Nature Genetics · doi:10.1038/ng0295-202 · Cited by 921 · cited 2×
“We studied crosses between Tg2576 mice (22) and mice deficient in the Nox2 catalytic subunit of NADPH oxidase (24).”
BackgroundMethodBrain infarction and the clinical expression of Alzheimer disease. The Nun Study.
Snowdon, D. A., Greiner, L. H., Mortimer, J. A., et al. (1997) · PubMed · Cited by 846
Regulation of the Cerebral Circulation: Role of Endothelium and Potassium Channels
FARACI, F. M., & HEISTAD, D. D. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.1.53 · Cited by 780 · cited 3×
“Thus, the restoration of responses to the endothelium-dependent vasodilators ACh, bradykinin, and A23187 cannot be attributed to an improvement in neuronal function because these responses are independent of neurons (25).”
BackgroundMethodNeurovascular mechanisms of Alzheimer's neurodegeneration
Zlokovic, B. V. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.02.001 · Cited by 770 · cited 2×
“The harmful cerebrovascular effects of A , in concert with epidemiological and pathological findings linking AD with cerebrovascular diseases (12–16), have suggested that A has deleterious actions both on neurons and cerebral blood vessels, which may act synergistically to induce brain dysfunction in AD (3, 17).”
BackgroundCerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study
Ruitenberg, A., den Heijer, T., Bakker, S. L. M., van Swieten, J. C., Koudstaal, P. J., Hofman, A., & Breteler, M. M. B. (2005) · Annals of Neurology · doi:10.1002/ana.20493 · Cited by 733
β-Amyloid-mediated vasoactivity and vascular endothelial damage
Thomas, T., Thomas, G., McLendon, C., Sutton, T., & Mullan, M. (1996) · Nature · doi:10.1038/380168a0 · Cited by 703 · cited 1×
“In vitro and in vivo studies have demonstrated that A enhances vasoconstriction, impairs responses to vasodilators, and reduces cerebral blood flow (CBF) (4, 5).”
BackgroundBrain Infarction and the Clinical Expression of Alzheimer Disease-Reply
Snowdon, D. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550020046024 · Cited by 674
Rey, F. E., Cifuentes, M. E., Kiarash, A., Quinn, M. T., & Pagano, P. J. (2001) · Circulation Research · doi:10.1161/hh1701.096037 · Cited by 605 · cited 1×
“21, the NADPH oxidase assembly peptide inhibitor gp91ds-tat (YGRKKRRQRRRCSTRIRRQL-NH2) and its scrambled control (sgp91ds-tat) (YGRKKRRQRRRCLRITRQSR-NH2) (Bio Synthesis) were studied (46).”
BackgroundSOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein
Iadecola, C., Zhang, F., Niwa, K., Eckman, C., Turner, S. K., Fischer, E., Younkin, S., Borchelt, D. R., Hsiao, K. K., & Carlson, G. A. (1999) · Nature Neuroscience · doi:10.1038/5715 · Cited by 399 · cited 4×
“A 1–40 and A 1–42 concentrations (picomoles per gram of brain tissue) were determined in supernatant (SDS-soluble) and the formic acid extract of the pellet (SDS-insoluble), using the BAN-50/BA-27 and BAN-50/BC005 sandwich ELISA as described (6, 7, 21).”
BackgroundMethodSelf-citationSarnyai, Z., Sibille, E. L., Pavlides, C., Fenster, R. J., McEwen, B. S., & Tóth, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.26.14731 · Cited by 396 · cited 2×
“Finally, we used a two-trial spatial-memory task in a Y maze (32, 33) to determine whether the reduced neurovascular dysfunction and oxidative stress in Tg2576/Nox2 / mice are associated with improved cognitive performance.”
MethodSelf-citationHolcomb, L. A., Gordon, M. N., Jantzen, P., Hsiao, K., Duff, K., & Morgan, D. (1999) · Behavior Genetics · doi:10.1023/a:1021691918517 · Cited by 353 · cited 1×
“First, it provides further evidence that in mouse models as in AD amyloid plaques do not predict the brain dysfunction underlying the cognitive deficits (41).”
BackgroundBrain Infarction and the Clinical Expression of Alzheimer Disease
Roman, G. C. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550020045023 · Cited by 350
Alzheimer's Disease and Mild Cognitive Impairment
Kelley, B. J., & Petersen, R. C. (2007) · Neurologic Clinics · doi:10.1016/j.ncl.2007.03.008 · Cited by 326
Dellu, F., Contarino, A., Simon, H., Koob, G. F., & Gold, L. H. (2000) · Neurobiology of Learning and Memory · doi:10.1006/nlme.1999.3919 · Cited by 303
Niwa, K., Kazama, K., Younkin, L., Younkin, S. G., Carlson, G. A., & Iadecola, C. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00022.2002 · Cited by 286
Self-citationCerebrovascular Reactivity and Cognitive Decline in Patients With Alzheimer Disease
Silvestrini, M., Pasqualetti, P., Baruffaldi, R., Bartolini, M., Handouk, Y., Matteis, M., Moffa, F., Provinciali, L., & Vernieri, F. (2006) · Stroke · doi:10.1161/01.str.0000206439.62025.97 · Cited by 278
Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice
Li, F., Calingasan, N. Y., Yu, F., Mauck, W. M., Toidze, M., Almeida, C. G., Takahashi, R. H., Carlson, G. A., Flint Beal, M., Lin, M. T., et al. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02455.x · Cited by 276 · cited 1×
“In contrast, enhancing mitochondrial ROS production by inactivation of one allele of mitochondrial superoxide dismutase increases the amyloid burden in mice overexpressing human APP (42, 43).”
BackgroundSelf-citationNox2-Derived Reactive Oxygen Species Mediate Neurovascular Dysregulation in the Aging Mouse Brain
Park, L., Anrather, J., Girouard, H., Zhou, P., & Iadecola, C. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600491 · Cited by 275 · cited 8×
“Considering that aging attenuates CBF responses also in WT mice via Nox2-derived ROS (31), it is more likely that aging and the associated increase in brain A levels acted in concert to enhance oxidative stress and the vascular dysfunction.”
BackgroundSelf-citationEsposito, L., Raber, J., Kekonius, L., Yan, F., Yu, G.-Q., Bien-Ly, N., Puoliväli, J., Scearce-Levie, K., Masliah, E., & Mucke, L. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0482-06.2006 · Cited by 254 · cited 1×
“In contrast, enhancing mitochondrial ROS production by inactivation of one allele of mitochondrial superoxide dismutase increases the amyloid burden in mice overexpressing human APP (42, 43).”
BackgroundPark, L., Anrather, J., Zhou, P., Frys, K., Pitstick, R., Younkin, S., Carlson, G. A., & Iadecola, C. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.5207-04.2005 · Cited by 244
Self-citationAβ1–40-related reduction in functional hyperemia in mouse neocortex during somatosensory activation
Niwa, K., Younkin, L., Ebeling, C., Turner, S. K., Westaway, D., Younkin, S., Ashe, K. H., Carlson, G. A., & Iadecola, C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.17.9735 · Cited by 244 · cited 5×
“A 1–40 and A 1–42 concentrations (picomoles per gram of brain tissue) were determined in supernatant (SDS-soluble) and the formic acid extract of the pellet (SDS-insoluble), using the BAN-50/BA-27 and BAN-50/BC005 sandwich ELISA as described (6, 7, 21).”
BackgroundMethodSelf-citationBehavioral characterization of the Tg2576 transgenic model of Alzheimer's disease through 19 months
King, D. L., & Arendash, G. W. (2002) · Physiology & Behavior · doi:10.1016/s0031-9384(02)00639-x · Cited by 242 · cited 2×
“These alterations are consistent with the behavioral deficits reported in Tg2576 mice (34).”
MethodResultShapira, I. L. (2008) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2008.0118 · Cited by 233
Beach, T. G., Wilson, J. R., Sue, L. I., Newell, A., Poston, M., Cisneros, R., Pandya, Y., Esh, C., Connor, D. J., Sabbagh, M., et al. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0136-y · Cited by 233
Liang, X., Wang, Q., Hand, T., Wu, L., Breyer, R. M., Montine, T. J., & Andreasson, K. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3591-05.2005 · Cited by 226
Niwa, K., Kazama, K., Younkin, S. G., Carlson, G. A., & Iadecola, C. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0460 · Cited by 218
Self-citationNathan, C., Calingasan, N., Nezezon, J., Ding, A., Lucia, M. S., La Perle, K., Fuortes, M., Lin, M., Ehrt, S., Kwon, N. S., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051529 · Cited by 214
Cyclooxygenase-1 Participates in Selected Vasodilator Responses of the Cerebral Circulation
Niwa, K., Haensel, C., Ross, M. E., & Iadecola, C. (2001) · Circulation Research · doi:10.1161/01.res.88.6.600 · Cited by 212 · cited 1×
“ACh increases CBF by activating endothelial nitric oxide synthase via endothelial muscarinic receptors (26, 27), bradykinin acts through endothelial bradykinin receptors and cyclooxygenase-1 products (28–30), and A23187 increases CBF in a receptor independent manner via cyclooxygenase-1 products (25, 30).”
BackgroundSelf-citationChow, N., Bell, R. D., Deane, R., Streb, J. W., Chen, J., Brooks, A., Van Nostrand, W., Miano, J. M., & Zlokovic, B. V. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608251104 · Cited by 209 · cited 1×
“However, a contribution from the alterations in smooth muscle contractility induced by myocardin in Tg2576 mice cannot be ruled out (37).”
BackgroundAβ-peptides enhance vasoconstriction in cerebral circulation
Niwa, K., Porter, V. A., Kazama, K., Cornfield, D., Carlson, G. A., & Iadecola, C. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.281.6.h2417 · Cited by 202 · cited 1×
“In vitro and in vivo studies have demonstrated that A enhances vasoconstriction, impairs responses to vasodilators, and reduces cerebral blood flow (CBF) (4, 5).”
BackgroundSelf-citationSobey, C. G., Heistad, D. D., & Faraci, F. M. (1997) · Stroke · doi:10.1161/01.str.28.11.2290 · Cited by 182
TAKANO, T., HAN, X., DEANE, R., ZLOKOVIC, B., & NEDERGAARD, M. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1379.004 · Cited by 168 · cited 1×
“For example, the increase in CBF induced by neural activity (functional hyperemia), a response that matches the brain’s energy demands with its blood supply, and the ability of cerebral endothelial cells to regulate CBF are profoundly impaired in mice overexpressing APP (7, 10).”
BackgroundTong, X.-K., Nicolakakis, N., Kocharyan, A., & Hamel, E. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4031-05.2005 · Cited by 152
Beckmann, N., Schuler, A., Mueggler, T., Meyer, E. P., Wiederhold, K.-H., Staufenbiel, M., & Krucker, T. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-24-08453.2003 · Cited by 149 · cited 1×
“Other investigators examined the effect of APP overexpression on the morphology of cerebral arteries and cerebral blood volume in mice at an age when amyloid deposition was thought to be present (35, 36).”
BackgroundNSAID and Antioxidant Prevention of Alzheimer's Disease: Lessons from In Vitro and Animal Models
COLE, G. M., MORIHARA, T., LIM, G. P., YANG, F., BEGUM, A., & FRAUTSCHY, S. A. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1332.005 · Cited by 129 · cited 2×
“Treatment with agents that scavenge ROS have been reported to ameliorate behavioral deficits in Tg2576 mice (40).”
BackgroundPark, L., Anrather, J., Forster, C., Kazama, K., Carlson, G. A., & Iadecola, C. (2004) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000105800.49957.1e · Cited by 127 · cited 2×
“However, these studies were performed in 3- to 4-month-old Tg2576 mice, an age when amyloid plaques and behavioral deficits are not yet present (18, 22, 23).”
BackgroundSelf-citationPerfusion abnormalities in prodromal AD
Johnson, K. A., & Albert, M. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00137-8 · Cited by 110 · cited 1×
“The vasoconstriction induced by A may underlie the marked reductions in CBF observed in the early stages of AD (11).”
BackgroundBussière, T., Friend, P. D., Sadeghi, N., Wicinski, B. A., Lin, G. I., Bouras, C., Giannakopoulos, P., Robakis, N. K. R. K., Morrison, J. H., Perl, D. P., et al. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00056-8 · Cited by 110
Effects of a Novel Inhibitor of Guanylyl Cyclase on Dilator Responses of Mouse Cerebral Arterioles
Sobey, C. G., & Faraci, F. M. (1997) · Stroke · doi:10.1161/01.str.28.4.837 · Cited by 105 · cited 1×
“ACh increases CBF by activating endothelial nitric oxide synthase via endothelial muscarinic receptors (26, 27), bradykinin acts through endothelial bradykinin receptors and cyclooxygenase-1 products (28–30), and A23187 increases CBF in a receptor independent manner via cyclooxygenase-1 products (25, 30).”
BackgroundCompromised Hemodynamic Response in Amyloid Precursor Protein Transgenic Mice
Mueggler, T., Sturchler-Pierrat, C., Baumann, D., Rausch, M., Staufenbiel, M., & Rudin, M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-16-07218.2002 · Cited by 101
Mueggler, T., Baumann, D., Rausch, M., Staufenbiel, M., & Rudin, M. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-23-08231.2003 · Cited by 81 · cited 1×
“Other investigators examined the effect of APP overexpression on the morphology of cerebral arteries and cerebral blood volume in mice at an age when amyloid deposition was thought to be present (35, 36).”
BackgroundHypertension and Related Factors in the Etiology of Alzheimer's Disease
SKOOG, I., & GUSTAFSON, D. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04796.x · Cited by 57
Calcium ionophore and acetylcholine dilate arterioles on the mouse brain by different mechanisms.
Rosenblum, W. I., McDonald, M., & Wormley, B. (1989) · Stroke · doi:10.1161/01.str.20.10.1391 · Cited by 32 · cited 1×
“ACh increases CBF by activating endothelial nitric oxide synthase via endothelial muscarinic receptors (26, 27), bradykinin acts through endothelial bradykinin receptors and cyclooxygenase-1 products (28–30), and A23187 increases CBF in a receptor independent manner via cyclooxygenase-1 products (25, 30).”
BackgroundMayhan, W. G. (1996) · Brain Research · doi:10.1016/s0006-8993(96)01000-1 · Cited by 22
Cited by
Gorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811
Self-citationThe Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease
Iadecola, C. (2017) · Neuron · doi:10.1016/j.neuron.2017.07.030 · Cited by 2,480
Self-citationSharifi-Rad, M., Anil Kumar, N. V., Zucca, P., Varoni, E. M., Dini, L., Panzarini, E., Rajkovic, J., Tsouh Fokou, P. V., Azzini, E., Peluso, I., et al. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00694 · Cited by 1,971
The Pathobiology of Vascular Dementia
Iadecola, C. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.008 · Cited by 1,857
“The vascular alterations induced by Ab are abrogated by overexpression of the ROS scavenging enzyme superoxide dismutase or deficiency of the NADPH oxidase subunit NOX2 (Iadecola et al., 1999; Park et al., 2005; 2008), implicating ROS produced by the enzyme NADPH oxidase in the vascular dysfunction.”
Self-citationAlzheimer’s Disease: The Challenge of the Second Century
Holtzman, D. M., Morris, J. C., & Goate, A. M. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002369 · Cited by 1,424
Metadata
- Authors
- Park, L., Zhou, P., Pitstick, R., Capone, C., Anrather, J., Norris, E. H., Younkin, L., Younkin, S., Carlson, G., McEwen, B. S., & Iadecola, C.
- Affiliations
- Cornell University (US)
- McLaughlin Research Institute (US)
- Rockefeller University (US)
- Mayo Clinic (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2008-01-29
- Volume
- 105
- Issue
- 4
- Pages
- 1347-1352
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2234141
- OpenAlex
- W2133933381
- Cited by
- 332
- References
- 51
- Citations by year
- 2026: 10 · 2025: 14 · 2024: 10 · 2023: 15 · 2022: 12 · 2021: 17 · 2020: 20 · 2019: 18 · 2018: 12 · 2017: 25 · 2016: 22 · 2015: 8 · 2014: 31 · 2013: 22 · 2012: 26
- FWCI
- 15.58
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke (NS-37853, R01NS037853)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Keywords
- NOX2, NADPH oxidase, reactive oxygen species, Alzheimer's disease, amyloid precursor protein, Tg2576 mice, Swedish mutation, cerebrovascular dysfunction, oxidative stress, amyloid-beta, amyloid plaques, neurovascular dysfunction, cognitive decline, behavioral deficits
- MeSH terms
- NADPH Oxidase 2, Amino Acid Sequence, Animals, Behavioral Symptoms, Brain, Cerebrovascular Circulation, Disease Models, Animal, Female, Free Radicals, Humans, Hyperemia, Male, Membrane Glycoproteins, Mice, Inbred C57BL, Mice, Transgenic, Molecular Sequence Data, Amyloid beta-Protein Precursor, Mice, Knockout, Maze Learning, NADPH Oxidases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.